FIELD: pharmacology.
SUBSTANCE: compounds of formula I can be used to prepare compounds possessing the properties of an ACT kinase inhibitor for treatment of diseases such as cancer. The method for preparation of a compound of formula I comprises cyclising of a compound of formula II or a salt thereof, wherein R1 is t-butoxycarbonyl; R2 is -COORa, where Ra is hydrogen or unsubstituted C1-4 alkyl, or R2 is-CONRaRb, where Ra is unsubstituted C1-4 alkyl and Rb is -ORc, phenyl; or Ra and Rb are taken together with the atom to which they are attached to form a 5-7 membered heterocyclyl, further comprising an oxygen atom; Rc is C1-4 alkyl; and M is Li or Mg. At that, a compound of formula II or a salt thereof obtained by contacting of a compound of formula III or a salt thereof, wherein R3 is bromine or iodine, with a magnesium or lithium metal-containing agent, for example alkyl magnesium halide, is used. The compound of formula III is usually prepared by reacting a compound of formula IV or a salt thereof with compound to produce a compound of formula V or a salt thereof, wherein R4 is -Cl or -OH, R1 and R2 have the values indicated above. The invention also relates to new intermediates, a compound of formula III and a compound of formula IV.
EFFECT: method allows to obtain products on an industrial scale with comparable or increased yield and quality of products.
22 cl, 1 tbl, 6 ex
,
Title | Year | Author | Number |
---|---|---|---|
NOVEL IMMUNE SYSTEM MODULATORS RELATED APPLICATIONS | 2012 |
|
RU2606114C2 |
PROTEIN-TARGETED COMPOUNDS, THEIR COMPOSITIONS, METHODS AND APPLICATIONS | 2016 |
|
RU2694895C2 |
MACROCYCLIC SERINE PROTEASE INHIBITORS | 2009 |
|
RU2490272C2 |
ANTIVIRAL COMPOUNDS | 2009 |
|
RU2505540C2 |
PEPTIDES AND PHARMACEUTICAL COMPOSITIONS FOR TREATING EYE DISEASES | 2019 |
|
RU2819399C2 |
MONOMER DERIVATIVES OF GLYCOPEPTIDE ANTIBIOTIC | 2005 |
|
RU2424248C2 |
THIAZOLIDINONE COMPOUNDS AND USE THEREOF FOR TREATING MENTAL OR NEUROLOGICAL DISORDERS AND INFLAMMATION, PARTICULARLY NEUROINFLAMMATION | 2015 |
|
RU2734253C2 |
ANTIMICROBIAL COMPOUNDS AND COMPOSITIONS | 2014 |
|
RU2630693C2 |
TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE | 2019 |
|
RU2815647C2 |
OBESITY TREATMENT | 2019 |
|
RU2822679C2 |
Authors
Dates
2018-02-06—Published
2013-05-17—Filed